In this study, we demonstrated increased evening levels of BDNF and proBDNF in patients with OSA who scored high on questionnaires assessing poor sleep quality and insomnia symptoms (PSQI and AIS, respectively). Here, BDNF is linked to obstructive sleep apnea syndrome.